Diagnosis of Secondary Adrenal Insufficiency: Unstimulated Early Morning Cortisol in Saliva and Serum in Comparison with the Insulin Tolerance Test

Abstract

Unstimulated early morning cortisol has been suggested as a first line parameter to assess adrenal function in patients with suspected secondary adrenal insufficiency. The measurement of basal salivary cortisol (BSaC) instead of basal serum cortisol (BSeC) offers some advantages, such as painless sampling and the determination of the free hormone. The objective of this study was to evaluate the diagnostic value of BSeC and BSaC in comparison to the insulin tolerance test (ITT). Seventy-seven patients with hypothalamic-pituitary disease and 184 healthy controls were enrolled. ITT were performed in patients, and BSeC as well as BSaC levels were measured in patients and controls. Upper and lower thresholds (with ≥95% specificity either for adrenal sufficiency or adrenal insufficiency) were calculated by ROC analysis both for BSeC and BSaC. The ITT identified 41 patients as adrenal insufficient and 36 patients as adrenal sufficient. Upper and lower cutoffs were 470 and 103 nmol/l for BSeC, and 21.1 and 5.0 nmol/l for BSaC, respectively. Thereby, basal cortisol allowed a highly specific diagnosis (i.e., similar to the ITT result) in either 23% (BSeC) or 27% (BSaC) of patients. We suggest the determination of unstimulated early morning cortisol as first-line screening method for the diagnosis of secondary adrenal insufficiency. If upper and lower cutoffs are used, dynamic testing could be obviated in about one fourth of cases. Due to its easy and painless collection BSaC may be preferable to BSeC.

Key words

basal cortisol - hypothalamic-pituitary-adrenal axis - hypopituitarism - adrenal cortex - adrenocortical insuffiency

References

• 1 Arlt W, Allolio B. Adrenal insufficiency.  Lancet. 2003;  361 1881-1893
• 2 Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency.  Ann Intern Med. 2003;  139 194-204
• 3 Shah A, Stanhope R, Matthew D. Hazards of pharmacological tests of growth hormone secretion in childhood.  BMJ. 1992;  304 173-174
• 4 Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency.  Clin Endocrinol (Oxf). 1987;  26 221-226
• 5 Watts NB, Tindall GT. Rapid assessment of corticotropin reserve after pituitary surgery.  JAMA. 1988;  259 708-711
• 6 Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test.  J Clin Endocrinol Metab. 1998;  83 2350-2354
• 7 Jones SL, Trainer PJ, Perry L, Wass JA, Besser GM, Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year.  Clin Endocrinol (Oxf). 1994;  41 123-128
• 8 Schmidt IL, Lahner H, Mann K, Petersenn S. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.  J Clin Endocrinol Metab. 2003;  88 4193-4198
• 9 Lewis JG. Steroid Analysis in Saliva: An overview.  Clin Biochem Rev. 2006;  27 139-146
• 10 Meulenberg PM, Ross HA, Swinkels LM, Benraad TJ. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone.  Clin Chim Acta. 1987;  165 379-385
• 11 Umeda T, Hiramatsu R, Iwaoka T, Shimada T, Miura F, Sato T. Use of saliva for monitoring unbound free cortisol levels in serum.  Clin Chim Acta. 1981;  110 245-253
• 12 Riad-Fahmy D, Read GF, Walker RF, Griffiths K. Steroids in saliva for assessing endocrine function.  Endocr Rev. 1982;  3 367-395
• 13 Vining RF, McGinley RA, Symons RG. Hormones in saliva: mode of entry and consequent implications for clinical interpretation.  Clin Chem. 1983;  29 1752-1756
• 14 Groschl M, Wagner R, Rauh M, Dorr HG. Stability of salivary steroids: the influences of storage, food and dental care.  Steroids. 2001;  66 737-741
• 15 Chen YM, Cintron NM, Whitson PA. Long-term storage of salivary cortisol samples at room temperature.  Clin Chem. 1992;  38 304
• 16 Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.  J Clin Endocrinol Metab. 1999;  84 878-882
• 17 Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.  J Clin Endocrinol Metab. 2002;  87 4515-4521
• 18 Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.  J Clin Endocrinol Metab. 2003;  88 4153-4157
• 19 Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome.  J Clin Endocrinol Metab. 1998;  83 2681-2686
• 20 Trilck M, Flitsch J, Ludecke DK, Jung R, Petersenn S. Salivary cortisol measurement – a reliable method for the diagnosis of Cushing's syndrome.  Exp Clin Endocrinol Diabetes. 2005;  113 225-230
• 21 Reynolds RM, Stewart PM, Seckl JR, Padfield PL. Assessing the HPA axis in patients with pituitary disease: a UK survey.  Clin Endocrinol (Oxf). 2006;  64 82-85
• 22 Tuchelt H, Dekker K, Bahr V, Oelkers W. Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease.  Clin Endocrinol (Oxf). 2000;  53 301-307
• 23 Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency.  J Clin Endocrinol Metab. 1994;  79 923-931
• 24 Aardal-Eriksson E, Karlberg BE, Holm AC. Salivary cortisol – an alternative to serum cortisol determinations in dynamic function tests.  Clin Chem Lab Med. 1998;  36 215-222
• 25 Contreras LN, Arregger AL, Persi GG, Gonzalez NS, Cardoso EM. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.  Clin Endocrinol (Oxf). 2004;  61 675-682
• 26 Marcus-Perlman Y, Tordjman K, Greenman Y, Limor R, Shenkerman G, Osher E, Stern N. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test.  Clin Endocrinol (Oxf). 2006;  64 215-218
• 27 Cetinkaya S, Ozon A, Yordam N. Diagnostic value of salivary cortisol in children with abnormal adrenal cortex functions.  Horm Res. 2007;  67 301-306
• 28 Laudat MH, Cerdas S, Fournier C, Guiban D, Guilhaume B, Luton JP. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function.  J Clin Endocrinol Metab. 1988;  66 343-348
• 29 Aardal E, Holm AC. Cortisol in saliva – reference ranges and relation to cortisol in serum.  Eur J Clin Chem Clin Biochem. 1995;  33 927-932
• 30 Clements AD, Parker CR. The relationship between salivary cortisol concentrations in frozen versus mailed samples.  Psychoneuroendocrinology. 1998;  23 613-616
• 31 Endert E, Ouwehand A, Fliers E, Prummel MF, Wiersinga WM. Establishment of reference values for endocrine tests. Part IV: Adrenal insufficiency.  Neth J Med. 2005;  63 435-443
• 32 Patel RS, Shaw SR, Macintyre H, McGarry GW, Wallace AM. Production of gender-specific morning salivary cortisol reference intervals using internationally accepted procedures.  Clin Chem Lab Med. 2004;  42 1424-1429
• 33 Raff H, Homar PJ, Burns EA. Comparison of two methods for measuring salivary cortisol.  Clin Chem. 2002;  48 207-208
• 34 Inder WJ, Hunt PJ. Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management.  J Clin Endocrinol Metab. 2002;  87 2745-2750
• 35 Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B, Atkinson AB. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.  Clin Endocrinol (Oxf). 2000;  53 431-436
• 36 Hout WM, Arafah BM, Salazar R, Selman W. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?.  J Clin Endocrinol Metab. 1988;  66 1208-1212
• 37 Auchus RJ, Shewbridge RK, Shepherd MD. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?.  Clin Endocrinol (Oxf). 1997;  46 21-27
• 38 Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism.  Clin Endocrinol (Oxf). 1994;  41 511-516
• 39 Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, Zappulli D, Cavagnini F. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.  Eur J Endocrinol. 2001;  145 165-171
• 40 Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.  Clin Endocrinol (Oxf). 2005;  63 642-649
• 41 Suri D, Moran J, Hibbard JU, Kasza K, Weiss RE. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test.  J Clin Endocrinol Metab. 2006;  91 3866-3872
• 42 Thomson AH, Devers MC, Wallace AM, Grant D, Campbell K, Freel M, Connell JM. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.  Clin Endocrinol (Oxf). 2007;  66 789-796

Correspondence